scispace - formally typeset
I

Ian M. Carr

Researcher at University of Leeds

Publications -  120
Citations -  5970

Ian M. Carr is an academic researcher from University of Leeds. The author has contributed to research in topics: Gene & Exome sequencing. The author has an hindex of 37, co-authored 118 publications receiving 5032 citations. Previous affiliations of Ian M. Carr include University of Washington & University of Florida.

Papers
More filters
Journal ArticleDOI

Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response.

Gillian I. Rice, +50 more
- 14 Jun 2009 - 
TL;DR: Mutations in SAMHD1 are described as the cause of Aicardi-Goutières syndrome at the AGS5 locus and data is presented to show that SAM HD1 may act as a negative regulator of the cell-intrinsic antiviral response.
Journal ArticleDOI

Identification of Microcephalin, a Protein Implicated in Determining the Size of the Human Brain

TL;DR: It is reported that a gene within this interval, encoding a BRCA1 C-terminal domain-containing protein, is mutated in MCPH1 families sharing an ancestral 8p23 haplotype, and this gene, microcephalin, is expressed in the developing cerebral cortex of the fetal brain.
Journal ArticleDOI

Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome

Gillian I. Rice, +117 more
TL;DR: The analysis defines the phenotypic spectrum of AGS and suggests a coherent mutation-screening strategy in this heterogeneous disorder, and indicates that at least one further AGS-causing gene remains to be identified.
Journal ArticleDOI

Identification of SATB2 as the cleft palate gene on 2q32-q33

TL;DR: High-resolution FISH mapping of two de novo CPO-associated translocations involving 2q32-q33 shows that one breakpoint interrupts the transcription unit of the gene encoding the DNA-binding protein SATB2 (formerly KIAA1034), which shows a remarkable degree of evolutionary conservation.
Journal ArticleDOI

Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy

TL;DR: These findings not only suggest therapies for PHO, but also imply that clubbing secondary to other pathologies may be prostaglandin mediated, and testing for HPGD mutations and biochemical testing forHPGD deficiency in patients with unexplained clubbing might help to obviate extensive searches for occult pathology.